Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2636311000168110 | Impavido (miltefosine 50 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2636321000168115 | Impavido 50 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Impavido 50 mg capsule | Is a | Impavido | true | Inferred relationship | Some | ||
| Impavido 50 mg capsule | Is a | miltefosine 50 mg capsule | true | Inferred relationship | Some | ||
| Impavido 50 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Impavido 50 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Impavido 50 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 531538725 | |
| Impavido 50 mg capsule | has intended active ingredient | miltefosine | true | Inferred relationship | Some | 531538724 | |
| Impavido 50 mg capsule | has Australian BoSS | miltefosine | true | Inferred relationship | Some | 531538724 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Impavido (miltefosine 50 mg) capsule, 28 capsules (trade product pack) | has TPUU | True | Impavido 50 mg capsule | Inferred relationship | Some | 1 |
| Impavido 50 mg capsule, 28, blister pack | has TPUU | True | Impavido 50 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR